Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.
Search results for: pediatric rheumatology
ACR Image Competition 2024 Results, Part 2—People’s Choice
The 2024 Image Competition showcased images representing a diverse range of pediatric patients. Here, we showcase the images from Europe and Central Asia, which were selected by ACR Convergence 2024 attendees in the first plenary session to receive the People’s Choice Award. A Rare Presentation of a Rare Disease An 18-month-old boy from Angola was…
Weathering the Cytokine Storm: Macrophage Activation Syndrome in Adults & Children
Peter Nigrovic, MD, provides a practical guide to the diagnosis & treatment of macrophage activation syndrome (MAS) in children & adults.
ACR Image Competition 2024 Results, Part 1—Best Overall
For the 2024 Image Competition, the ACR sought images representing a diverse range of patients with educational or remarkable manifestations of pediatric rheumatic diseases, including autoimmune, inflammatory, infectious and malignant drivers of pediatric rheumatic disease. Here, we showcase the images selected as Best Overall. Cavitary Lung Nodules with Sinus & Skin Disease in Pediatric ANCA-Associated…
The ABCs of RCTs
At this ACR Convergence 2024 session, experts discussed new and creative ways to design trials to account for real-world scenarios and to produce information relevant to practicing clinicians.
The 2024 ARP President’s & Merit Awards
ARP members honored for significant contributions to rheumatology research, education and patient care.
What Does Being an ACR Master Mean? ACR’s 2024 Master’s Class Honored
The ACR honored 19 members for outstanding contributions to the ACR and the field of rheumatology.
ACR Honors Distinguished Fellows: Class of 2024
At ACR Convergence 2024, the ACR honored clinical and research fellows in programs from New York to California and points between.
Rheum After 5: Dr. Elizabeth Hazel, Olympian
Dr. Elizabeth Hazel reflects on her experience as a Canadian swimming competitor in the 1992 Summer Olympics.
AC&R Study Summary: Standardizing Treatment for Moderately Severe JDM
Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 95
- Next Page »